blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2097439

EP2097439 - PEPTIDES [Right-click to bookmark this link]
Former [2009/37]NOVEL PEPTIDES
[2012/39]
StatusNo opposition filed within time limit
Status updated on  03.01.2014
Database last updated on 31.08.2024
Most recent event   Tooltip04.09.2015Lapse of the patent in a contracting state
New state(s): MT		published on 07.10.2015  [2015/41]
Applicant(s)For all designated states
Faron Ventures OY
Tykistökatu 6 B
20520 Turku / FI
[2009/37]
Inventor(s)01 / KIVI, Elina
Zähringer Strasse 303
79108 Freiburg / DE
02 / ELIMA, Kati
Metsäpirtinkatu 25
20740 Turku / FI
03 / JALKANEN, Sirpa
Rauvolantie 79
20760 Piispanristi / FI
 [2009/43]
Former [2009/37]01 / KIVI, Elina
Itäinen Pitkäkatu 10 A 7
20520 Turku / FI
02 / ELIMA, Kati
Metsäpirtinkatu 25
20740 Turku / FI
03 / JALKANEN, Sirpa
Rauvolantie 79
20760 Piispanristi / FI
Representative(s)Öhman, Ann-Marie
Kaivokatu 15 B 23
20520 Turku / FI
[2013/09]
Former [2009/37]Öhman, Ann-Marie
Kaivokatu 15 B 23
20520 Turku / FI
Application number, filing date07858320.018.12.2007
[2009/37]
WO2007FI00296
Priority number, dateFI2006000115627.12.2006         Original published format: FI 20061156
[2009/37]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008077993
Date:03.07.2008
Language:EN
[2008/27]
Type: A1 Application with search report 
No.:EP2097439
Date:09.09.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 03.07.2008 takes the place of the publication of the European patent application.
[2009/37]
Type: B1 Patent specification 
No.:EP2097439
Date:27.02.2013
Language:EN
[2013/09]
Search report(s)International search report - published on:FI03.07.2008
(Supplementary) European search report - dispatched on:EP06.05.2011
ClassificationIPC:C07K7/06, C07K14/47, A61K38/08, A61K49/00, G01N33/53, G01N33/68, C12N9/06
[2009/37]
CPC:
B82Y5/00 (EP,US); A61K47/66 (EP,US); A61K47/64 (EP,US);
A61P21/00 (EP); A61P29/00 (EP); A61P37/00 (EP);
A61P43/00 (EP); C07K14/705 (EP,US); C07K7/06 (EP,US);
A61K38/00 (EP,US); G01N2800/042 (EP,US); G01N2800/24 (EP,US);
G01N2800/32 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/37]
TitleGerman:PEPTIDE[2013/08]
English:PEPTIDES[2013/08]
French:PEPTIDES[2013/08]
Former [2009/37]NEUE PEPTIDE
Former [2009/37]NOVEL PEPTIDES
Former [2009/37]NOUVEAUX PEPTIDES
Entry into regional phase04.05.2009National basic fee paid 
04.05.2009Search fee paid 
04.05.2009Designation fee(s) paid 
04.05.2009Examination fee paid 
Examination procedure04.05.2009Examination requested  [2009/37]
06.10.2011Amendment by applicant (claims and/or description)
28.10.2011Despatch of a communication from the examining division (Time limit: M06)
14.03.2012Reply to a communication from the examining division
13.07.2012Despatch of a communication from the examining division (Time limit: M02)
11.08.2012Reply to a communication from the examining division
16.10.2012Communication of intention to grant the patent
09.01.2013Fee for grant paid
09.01.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  28.10.2011
Opposition(s)28.11.2013No opposition filed within time limit [2014/06]
Fees paidRenewal fee
23.12.2009Renewal fee patent year 03
17.12.2010Renewal fee patent year 04
20.12.2011Renewal fee patent year 05
13.12.2012Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU18.12.2007
AT27.02.2013
BE27.02.2013
CY27.02.2013
CZ27.02.2013
DK27.02.2013
EE27.02.2013
FI27.02.2013
IT27.02.2013
LT27.02.2013
LV27.02.2013
MC27.02.2013
MT27.02.2013
NL27.02.2013
PL27.02.2013
RO27.02.2013
SE27.02.2013
SI27.02.2013
SK27.02.2013
TR27.02.2013
BG27.05.2013
GR28.05.2013
ES07.06.2013
IS27.06.2013
PT27.06.2013
[2015/41]
Former [2015/34]HU18.12.2007
AT27.02.2013
BE27.02.2013
CY27.02.2013
CZ27.02.2013
DK27.02.2013
EE27.02.2013
FI27.02.2013
IT27.02.2013
LT27.02.2013
LV27.02.2013
MC27.02.2013
NL27.02.2013
PL27.02.2013
RO27.02.2013
SE27.02.2013
SI27.02.2013
SK27.02.2013
TR27.02.2013
BG27.05.2013
GR28.05.2013
ES07.06.2013
IS27.06.2013
PT27.06.2013
Former [2015/32]AT27.02.2013
BE27.02.2013
CY27.02.2013
CZ27.02.2013
DK27.02.2013
EE27.02.2013
FI27.02.2013
IT27.02.2013
LT27.02.2013
LV27.02.2013
MC27.02.2013
NL27.02.2013
PL27.02.2013
RO27.02.2013
SE27.02.2013
SI27.02.2013
SK27.02.2013
TR27.02.2013
BG27.05.2013
GR28.05.2013
ES07.06.2013
IS27.06.2013
PT27.06.2013
Former [2014/38]AT27.02.2013
BE27.02.2013
CY27.02.2013
CZ27.02.2013
DK27.02.2013
EE27.02.2013
FI27.02.2013
IT27.02.2013
LT27.02.2013
LV27.02.2013
MC27.02.2013
NL27.02.2013
PL27.02.2013
RO27.02.2013
SE27.02.2013
SI27.02.2013
SK27.02.2013
BG27.05.2013
GR28.05.2013
ES07.06.2013
IS27.06.2013
PT27.06.2013
Former [2014/03]AT27.02.2013
BE27.02.2013
CY27.02.2013
CZ27.02.2013
DK27.02.2013
EE27.02.2013
FI27.02.2013
IT27.02.2013
LT27.02.2013
LV27.02.2013
NL27.02.2013
PL27.02.2013
RO27.02.2013
SE27.02.2013
SI27.02.2013
SK27.02.2013
BG27.05.2013
GR28.05.2013
ES07.06.2013
IS27.06.2013
PT27.06.2013
Former [2013/52]AT27.02.2013
BE27.02.2013
CY27.02.2013
CZ27.02.2013
DK27.02.2013
EE27.02.2013
FI27.02.2013
LT27.02.2013
LV27.02.2013
NL27.02.2013
PL27.02.2013
RO27.02.2013
SE27.02.2013
SI27.02.2013
SK27.02.2013
BG27.05.2013
GR28.05.2013
ES07.06.2013
IS27.06.2013
PT27.06.2013
Former [2013/49]AT27.02.2013
BE27.02.2013
CZ27.02.2013
DK27.02.2013
EE27.02.2013
FI27.02.2013
LT27.02.2013
LV27.02.2013
NL27.02.2013
PL27.02.2013
RO27.02.2013
SE27.02.2013
SI27.02.2013
SK27.02.2013
BG27.05.2013
GR28.05.2013
ES07.06.2013
IS27.06.2013
PT27.06.2013
Former [2013/48]AT27.02.2013
BE27.02.2013
DK27.02.2013
EE27.02.2013
FI27.02.2013
LT27.02.2013
LV27.02.2013
NL27.02.2013
PL27.02.2013
SE27.02.2013
SI27.02.2013
BG27.05.2013
GR28.05.2013
ES07.06.2013
IS27.06.2013
PT27.06.2013
Former [2013/40]AT27.02.2013
BE27.02.2013
FI27.02.2013
LT27.02.2013
LV27.02.2013
PL27.02.2013
SE27.02.2013
SI27.02.2013
BG27.05.2013
GR28.05.2013
ES07.06.2013
IS27.06.2013
PT27.06.2013
Former [2013/38]AT27.02.2013
BE27.02.2013
FI27.02.2013
LT27.02.2013
LV27.02.2013
PL27.02.2013
SE27.02.2013
SI27.02.2013
BG27.05.2013
GR28.05.2013
ES07.06.2013
IS27.06.2013
Former [2013/37]AT27.02.2013
FI27.02.2013
LT27.02.2013
PL27.02.2013
SE27.02.2013
SI27.02.2013
BG27.05.2013
GR28.05.2013
ES07.06.2013
IS27.06.2013
Former [2013/36]AT27.02.2013
LT27.02.2013
PL27.02.2013
SE27.02.2013
BG27.05.2013
ES07.06.2013
IS27.06.2013
Former [2013/34]LT27.02.2013
SE27.02.2013
BG27.05.2013
IS27.06.2013
Former [2013/33]LT27.02.2013
Documents cited:Search[A]  - BONO P ET AL, "Cloning and characterization of mouse vascular adhesion protein-1 reveals a novel molecule with enzymatic activity.", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 1 JUN 1998, (19980601), vol. 160, no. 11, ISSN 0022-1767, pages 5563 - 5571, XP002558724 [A] 1,12-15 * the whole document *
 [A]  - TAKEDA SOICHI ET AL, "Crystal structures of VAP1 reveal ADAMs' MDC domain architecture and its unique C-shaped scaffold", EMBO (EUROPEAN MOLECULAR BIOLOGY ORGANIZATION) JOURNAL, (200606), vol. 25, no. 11, ISSN 0261-4189, pages 2388 - 2396, XP002558725 [A] 1,12-15 * the whole document *

DOI:   http://dx.doi.org/10.1038/SJ.EMBOJ.7601131
International search[A]WO2006128951  (FARON PHARMACEUTICALS OY [FI], et al);
 [A]  - VAINIO P.J. ET AL., "Safety of blocking vascular adhesion protein-1 in patients with contact dermatitis", BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, (200506), vol. 96, no. 6, pages 429 - 435, XP008106108

DOI:   http://dx.doi.org/10.1111/j.1742-7843.2005.pto_96605.x
 [A]  - JAAKKOLA K. ET AL., "In vivo detection of vascular adhesion protein-1 in experimental inflammation", AMERICAN JOURNAL OF PATHOLOGY, (200008), vol. 157, no. 2, pages 463 - 471, XP001197363
 [A]  - WANG E.Y. ET AL., "Design, synthesis, and biologcial evaluation of semicarbazide-sensitive amine oxidase (SSAO) inhibitors with anti-inflammatory activity", JOURNAL OF MEDICINAL CHEMISTRY, (200604), vol. 49, no. 7, pages 2166 - 2173, XP008106109

DOI:   http://dx.doi.org/10.1021/jm050538l
Examination   - K. AALTO ET AL, "Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer", BLOOD, (20110929), vol. 118, no. 13, doi:10.1182/blood-2010-09-311076, ISSN 0006-4971, pages 3725 - 3733, XP055035983

DOI:   http://dx.doi.org/10.1182/blood-2010-09-311076
by applicant   - R OLIYAI; VJ STELLA, ANNU. REV. PHARMACOL. TOXICOL., (1993), vol. 32, pages 521 - 44
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.